Accumulating evidence demonstrates that CXCL12 upregulation was implicated in AADs including IPF [51], rheumatoid arthritis (RA) [52], and amyotrophic lateral sclerosis (ALS) [53]. This evidence concerns the gene CXCL12 and idiopathic pulmonary fibrosis.